-
May 20, 2022
RADIOCHEMIST (UNDER CLASSIFICATION REVIEW)
Eastern Health, Newfoundland has a vacancy for a RADIOCHEMIST (UNDER CLASSIFICATION REVIEW) PET/CT Facility Diagnostic Imaging Program – Molecular Imaging (Nuclear Medicine) Permanent, Full-Time Apply online at https://employment.easternhealth.ca Upon successfully applying for a vacancy then you will receive a confirmation email. If you do not receive this email please contact Recruitment 777-7777 ext 5-2 immediately To […]
Read More -
April 22, 2022
11th International Conference on Isotopes (11ICI) Webinar Series April 28, 2022
You are invited to attend the 11th International Conference on Isotopes (11ICI) Webinar Series organized by Sylvia Fedoruk Canadian Centre for Nuclear Innovation in partnership with the University of Saskatchewan and Tourism Saskatoon. Webinar Series 1 of 4 Demand and Supply of Isotopes Around the World – From Diverse Perspectives April 28, 2022 *7:00 AM […]
Read More -
January 26, 2022
Alert: HFR Outage Will Impact Isotope Supply
NMEU COMMUNICATION 24 JAN 2022 Z January 26, 2022 On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks. The delay is due to discovery of […]
Read More -
January 28, 2021
CARS Newsletter Winter 2021
Find the latest news in our community on CARS Newsletter January 2021.
Read More -
October 7, 2020
Update – Calgary Radiopharmaceutical Centre announces availability of DISIDA kits
Dear colleagues, The Calgary Radiopharmaceutical Centre (CRC) is addressing the shortage of Mebrofenin kits. CRC announces the availability for distribution of Stannous DISIDA Kits used in hepatobiliary imaging. For information regarding orders send your request to CalgaryRadiopharm@ahs.ca, For details please contact: Ingrid Koslowsky, Director Calgary Radiopharmaceutical Centre Foothills Medical Centre 1433-29 St W Calgary, Alberta, Canada […]
Read More -
June 17, 2020
Mandatory Regulatory Enrolment Process, Effective October 01, 2020
On March 30, 2020, Health Canada published a Notice communicating that the use of the Regulatory Enrolment Process (REP) will be mandatory as of October 1, 2020, for pharmaceutical, biologic and radiopharmaceutical drugs for human use as well as disinfectants, pursuant to Part C, Division 1 and Division 8 of the Food and Drug Regulations. […]
Read More
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.